Rexahn Pharmaceuticals, Inc. (nyse mkt:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and financial results for the quarter ended June 30, 2014. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) belongs to Healthcare sector. Its weekly performance is 2.86%. On last trading day company shares ended up $0.71. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) distance from 50-day simple moving average (SMA50) is -9.38%.
ANADIGICS (NASDAQ:ANAD) was downgraded by Craig Hallum from a “buy” rating to a “hold” rating in a research note issued on Thursday. Anadigics, Inc. (NASDAQ:ANAD) shares moved down -1.56% in last trading session and ended the day at $0.63. ANAD Gross Margin is 9.70% and its return on assets is -52.20%. Anadigics, Inc. (NASDAQ:ANAD) quarterly performance is -43.75%.
Analysts at Credit Suisse assumed coverage on shares of Markit (NASDAQ:MRKT) in a research report issued to clients and investors on Tuesday. On 23 August, Markit Ltd. (NASDAQ:MRKT) shares moved down -0.55% and was closed at $25.39. MRKT EPS growth in last 5 year was 0.00%. Markit Ltd. (NASDAQ:MRKT) year to date (YTD) performance is -4.91%.
Educational Development Corporation (NASDAQ:EDUC) ended the last trading day at $4.73. Company weekly volatility is calculated as 2.88%and price to cash ratio as 63.07. Educational Development Corporation (NASDAQ:EDUC) showed a weekly performance of -2.47%.
On August 14,2014 Chindex International, Inc. (NASDAQ: CHDX), an American healthcare company providing premium quality healthcare services in China through the operations of United Family Healthcare (“UFH”), a network of private primary care hospitals and affiliated ambulatory clinics, announced financial results for the second quarter ended June 30, 2014.Chindex International Inc. (NASDAQ:CHDX) shares advanced 0.25% in last trading session and ended the day on $23.89. CHDX its return on assets is -4.20%. Chindex International Inc. (NASDAQ:CHDX) quarterly performance is 0.42%.